Beibei Guo

发表

MIDAS: a practical Bayesian design for platform trials with molecularly targeted agents.

Ying Yuan, Karen Lu, Beibei Guo, 2016, Statistics in medicine.

Bayesian dose-finding designs for combination of molecularly targeted agents assuming partial stochastic ordering

Beibei Guo, Yisheng Li, Yisheng Li, 2014, Statistics in medicine.

Optimal two-stage enrichment design correcting for biomarker misclassification

Beibei Guo, Yong Zang, Beibei Guo, 2018, Statistical methods in medical research.

Bayesian Phase I/II Biomarker-Based Dose Finding for Precision Medicine With Molecularly Targeted Agents

Ying Yuan, Beibei Guo, Ying Yuan, 2017, Journal of the American Statistical Association.

A Bayesian adaptive marker‐stratified design for molecularly targeted agents with customized hierarchical modeling

Sha Cao, Yong Zang, Chi Zhang, 2019, Statistics in medicine.

A Bayesian phase I/II clinical trial design in the presence of informative dropouts

Beibei Guo, Yong Zang, Ying Yuan, 2015 .

An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints

Suyu Liu, Beibei Guo, Beibei Guo, 2019, Biometrical journal. Biometrische Zeitschrift.

A dose-schedule finding design for phase I-II clinical trials.

Ying Yuan, Beibei Guo, Yisheng Li, 2016, Journal of the Royal Statistical Society. Series C, Applied statistics.

A Bayesian adaptive phase II clinical trial design accounting for spatial variation

Yong Zang, Beibei Guo, Beibei Guo, 2018, Statistical methods in medical research.

A Bayesian Phase I/II Trial Design for Immunotherapy

Ying Yuan, Beibei Guo, Ying Yuan, 2018, Journal of the American Statistical Association.

A utility‐based Bayesian phase I–II design for immunotherapy trials with progression‐free survival end point

Yeonhee Park, Beibei Guo, Beibei Guo, 2019 .

A comparative review of methods for comparing means using partially paired data

Ying Yuan, Beibei Guo, Ying Yuan, 2017, Statistical methods in medical research.